NexGel (NXGL) Competitors $2.41 -0.06 (-2.43%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$2.43 +0.02 (+1.00%) As of 09/12/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. ICCM, LUNG, QTI, NTRB, TELA, CTSO, SURG, PYPD, DXR, and SRTSShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include IceCure Medical (ICCM), Pulmonx (LUNG), QT Imaging (QTI), Nutriband (NTRB), TELA Bio (TELA), Cytosorbents (CTSO), SurgePays (SURG), PolyPid (PYPD), Daxor (DXR), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors IceCure Medical Pulmonx QT Imaging Nutriband TELA Bio Cytosorbents SurgePays PolyPid Daxor Sensus Healthcare NexGel (NASDAQ:NXGL) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Which has more risk & volatility, NXGL or ICCM? NexGel has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Is NXGL or ICCM more profitable? NexGel has a net margin of -25.02% compared to IceCure Medical's net margin of -317.62%. NexGel's return on equity of -49.37% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets NexGel-25.02% -49.37% -25.68% IceCure Medical -317.62%-136.96%-71.46% Does the media favor NXGL or ICCM? In the previous week, IceCure Medical had 3 more articles in the media than NexGel. MarketBeat recorded 5 mentions for IceCure Medical and 2 mentions for NexGel. NexGel's average media sentiment score of 1.33 beat IceCure Medical's score of 0.04 indicating that NexGel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IceCure Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, NXGL or ICCM? NexGel has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexGel$11.67M1.67-$3.28M-$0.40-6.03IceCure Medical$3.29M20.58-$15.32M-$0.16-6.16 Do insiders and institutionals hold more shares of NXGL or ICCM? 2.2% of NexGel shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 20.5% of NexGel shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer NXGL or ICCM? IceCure Medical has a consensus target price of $2.39, suggesting a potential upside of 142.01%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00IceCure Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryNexGel beats IceCure Medical on 10 of the 17 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.44M$6.88B$5.84B$10.14BDividend YieldN/A1.21%5.68%4.60%P/E Ratio-6.0226.0175.4125.98Price / Sales1.67191.21515.95180.52Price / CashN/A22.1337.5660.44Price / Book2.685.0012.156.29Net Income-$3.28M$176.38M$3.29B$271.07M7 Day Performance8.56%1.00%0.74%3.87%1 Month Performance8.07%2.09%5.00%5.49%1 Year Performance-11.40%10.96%62.55%25.86% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.8828 of 5 stars$2.41-2.4%N/A-11.4%$19.44M$11.67M-6.0210ICCMIceCure Medical2.3071 of 5 stars$1.03-1.9%$2.39+131.6%+59.0%$70.76M$3.29M-6.4460Short Interest ↑LUNGPulmonx3.5329 of 5 stars$1.69-0.6%$7.66+353.5%-79.5%$68.87M$83.79M-1.18250QTIQT ImagingN/A$2.52+1.6%N/A+388.0%$68.38M$4.00M0.00N/ANTRBNutriband2.9568 of 5 stars$6.05-3.4%$13.00+114.9%+60.0%$67.46M$2.14M-6.7210Earnings ReportShort Interest ↓TELATELA Bio2.7814 of 5 stars$1.60-1.2%$4.50+181.3%-40.4%$63.39M$69.30M-1.43120News CoveragePositive NewsCTSOCytosorbents2.6712 of 5 stars$1.00+1.6%$5.50+451.1%-13.1%$62.64M$36.11M-5.87220Positive NewsSURGSurgePays3.2532 of 5 stars$2.79+1.1%$9.00+222.6%+76.8%$57M$60.88M-1.1240Negative NewsPYPDPolyPid3.5167 of 5 stars$3.49+0.9%$12.40+255.3%+0.3%$55.49MN/A-0.9180Short Interest ↓DXRDaxor4.0874 of 5 stars$11.40-0.1%$25.00+119.3%+29.0%$55.18MN/A0.0037Short Interest ↓Gap UpSRTSSensus Healthcare2.6545 of 5 stars$3.27+1.2%$8.00+144.6%-47.8%$53.76M$41.81M-54.5040 Related Companies and Tools Related Companies ICCM Alternatives LUNG Alternatives QTI Alternatives NTRB Alternatives TELA Alternatives CTSO Alternatives SURG Alternatives PYPD Alternatives DXR Alternatives SRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts